Home Blog Pharmaceutical Litigation

Pharmaceutical Litigation

Stryker Accolade Hip Defects Lead to Patient Harm

Stryker Accolade Hip Defects Lead to Patient Harm

| Pharmaceutical Litigation
Stryker is one of the largest medical device and equipment manufacturing companies in the world, and is responsible for the creation of the Stryker Accolade. The Accolade (there are a number of different Accolade models, including the Accolade TMZF Plus and Accolade II, both of which have been recalled) refers to a hip stem. A…Read the article
New Jersey Law Journal Quotes Hunter Shkolnik About Diabetes Drug Lawsuit

New Jersey Law Journal Quotes Hunter Shkolnik About Diabetes Drug Lawsuit

| Pharmaceutical Litigation
In April 2016 the U.S. Food and Drug Administration (FDA) announced the need for stronger heart problem warnings on the diabetes drug saxagliptin, sold under the names Onglyza  and Kombigleze XR. A 2015  internal study conducted by the pharmaceutical companies themselves did find an increased for hospitalization for heart failure after saxagliptin use. A previous FDA bulletin…Read the article
Taxotere: What It Is and Why Some Women Are Suing

Taxotere: What It Is and Why Some Women Are Suing

| Pharmaceutical Litigation
Brand name Taxotere (docetaxel) is a the most commonly used drug in its class to treat breast cancer. According to BreastCancer.org, the drug works by interfering with the ability of cancer cells to divide, is given intravenously, and is used to treat patients suffering from both early stage breast cancer and advanced stage breast cancer.…Read the article
Napoli Shkolnik PLLC to Appear Before The United States Supreme Court

Napoli Shkolnik PLLC to Appear Before The United States Supreme Court

| Pharmaceutical Litigation
The issue being heard is a challenge to the California Supreme Court’s decision that out of state victims may sue in California. Next week, Plaintiffs, including representatives from Napoli Shkolnik, will appear before the United States Supreme Court.  The Court will consider a challenge to California’s highest court decision which upheld the rule of law…Read the article
Are You the Victim of a Stryker Hip Implant?

Are You the Victim of a Stryker Hip Implant?

| Pharmaceutical Litigation
Stryker hip implants are artificial joints that are designed to resemble a normal, healthy joint. Designed for those people who are experiencing debilitating pain in the hip, which cannot be relieved through other methods, including physical therapy and corticosteroid injections, Stryker hip implants are used in invasive hip replacement surgeries. While some implant procedures may…Read the article
Opioid Epidemic: A Crisis Many Americans Struggle With

Opioid Epidemic: A Crisis Many Americans Struggle With

| Pharmaceutical Litigation
In 2015, the opioid epidemic in America took the lives of more than 33,000 people. These people come from all backgrounds and income levels, races and family types. Today, opioid overdosing kills nearly as many people as do car accidents, and heroin deaths alone kill more people than do gun homicides. What’s Fueling the Opioid…Read the article
Abilify: Link to Compulsive Gambling

Abilify: Link to Compulsive Gambling

| Pharmaceutical Litigation
Abilify is one of the top-selling antipsychotic drugs in the United States and is often used to treat bipolar disorder, schizophrenia, and Tourette’s syndrome. However, the drug may be dangerous and lead to compulsive and risky behaviors. Many people who have taken Abilify have filed suit against the drug’s makers, Otsuka and Bristol-Myers Squibb,  alleging…Read the article
Partner Jennifer Liakos Named to Abilify Plaintiffs’ Steering Committee

Partner Jennifer Liakos Named to Abilify Plaintiffs’ Steering Committee

| Pharmaceutical Litigation
Congratulations Napoli Shkolnik partner Jennifer R. Liakos for being appointed on the Plaintiffs’ Steering Committee in the In re Abilify (Aripiprazole)) Products Liability Litigation (Case No. 3:16-md02734) by Chief United States District Judge M. Casey Rodgers. The Order states there were many applications for this multi-district litigation (MDL); however, the Court appointed the MDL leadership…Read the article
New York Law Journal and The Recorder Front Pages Highlight Napoli Shkolnik PLLC Litigation

New York Law Journal and The Recorder Front Pages Highlight Napoli Shkolnik PLLC Litigation

| Pharmaceutical Litigation
As was reported by Tony Mauro of the NYLJ and Ben Hancock of The Recorder, personal jurisdiction cases are a hot issue right now, with four cases pending before the U.S. Supreme Court. In the Bristol-Myers case, the California Supreme Court ruled that both in-state and out-of-state plaintiffs could sue the pharmaceutical company in California…Read the article
NYLJ Reports: J&J Knew Cancer Risks Associated with Talc-Based Products

NYLJ Reports: J&J Knew Cancer Risks Associated with Talc-Based Products

| Pharmaceutical Litigation
Johnson & Johnson has known about the increased ovarian cancer risk associated with the use of their talc-based products but failed to warn women who used it. In fact, the supposed family friendly company did nothing, not even putting a warning label on the box despite the numerous research studies showing the connection between talcum…Read the article

Contact Us

Get a free case evaluation Attorney Referral

For all other inquiry types, please Contact Us or call (844) 230-7676

GET HELP NOW